A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/42 (2006.01) A61M 1/14 (2006.01) A61M 1/34 (2006.01) A61K 35/14 (2006.01)
Patent
CA 2738930
Methods for reducing or eliminating biomaterial-induced procoagulant activity in blood subjected to extracorporeal treatment that exposes the blood to the biomaterial are disclosed. The methods involve treatment of the blood, or the extracorporeal biomaterial, or both, with a complement inhibitor to inhibit C5a/C5aR-mediated tissue factor formation in the blood.
La présente invention concerne des procédés destinés à réduire ou à éliminer une activité procoagulante induite par des biomatériaux dans le sang soumis à un traitement extracorporel qui expose le sang au biomatériau. Les procédés comprennent le traitement du sang, ou du biomatériau extracorporel, ou des deux, par un inhibiteur du complément afin dinhiber la formation de facteurs tissulaires induits par les C5a/C5aR dans le sang.
Lambris John D.
Ritis Konstantinos
Mccarthy Tetrault Llp
Ritis Konstantinos
The Trustees Of The University Of Pennsylvania
LandOfFree
Method of inhibiting biomaterial-induced procoagulant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting biomaterial-induced procoagulant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting biomaterial-induced procoagulant... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1473123